Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial (PROBE)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04510597 |
Recruitment Status :
Recruiting
First Posted : August 12, 2020
Last Update Posted : August 14, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Metastatic Clear Cell Renal Cell Carcinoma Metastatic Renal Cell Carcinoma Stage IV Renal Cell Cancer AJCC v8 | Procedure: Cytoreductive Nephrectomy Drug: Active Comparator | Phase 3 |
PRIMARY OBJECTIVE:
I. To compare overall survival in participants with newly diagnosed metastatic renal cell carcinoma who are randomized to receive immune checkpoint inhibitor-based combination treatment plus cytoreductive nephrectomy versus immune checkpoint inhibitor-based combination treatment alone.
SECONDARY OBJECTIVES:
I. To compare overall survival between arms in the subset who received their assigned protocol treatment.
II. To assess complications of nephrectomy and post-randomization drug toxicities.
III. To compare objective response rate in metastatic sites between the arms in participants with measurable metastatic disease.
IV. To assess change in diameter of primary tumor at week 12 disease assessment in participants who have received pre-randomization treatment.
BANKING OBJECTIVE:
I. To bank specimens for future correlative studies.
OUTLINE:
PRE-RANDOMIZATION TREATMENT: Treatment naive patients are assigned to 1 of 3 treatment regimens per standard of care.
REGIMEN I: Patients receive nivolumab intravenously (IV) and ipilimumab IV. Treatment repeats every 3 weeks for up to 4 cycles in the absence of disease progression or unacceptable toxicity. Patients then receive nivolumab IV on day 1. Cycles repeat every 2-4 weeks in the absence of disease progression or unacceptable toxicity.
REGIMEN II: Patients receive pembrolizumab IV on day 1 and axitinib orally (PO) twice daily (BID) on days 1-21. Cycles repeat every 3 weeks in the absence of disease progression or unacceptable toxicity.
REGIMEN III: Patients receive avelumab IV on day 1 and axitinib PO BID on days 1-14. Cycles repeat every 2 weeks in the absence of disease progression or unacceptable toxicity.
NOTE: Some patients may have already completed the standard of care pre-randomization treatment specified above off-trial.
RANDOMIZATION TREATMENT: Between 10-14 weeks from the start of on-trial or off-trial pre-randomization treatment, patients are randomized to 1 of 2 arms.
ARM I: Patients receive nivolumab IV, pembrolizumab IV, or avelumab IV on day 1. Patients also receive axitinib PO BID. Cycles with nivolumab repeat every 2 or 4 weeks, cycles with pembrolizumab repeat every 3 weeks, and cycles with avelumab repeat every 2 weeks in the absence of disease progression or unacceptable toxicity.
ARM II: Within 42 days following randomization, patients undergo radical or partial nephrectomy in addition to nivolumab, pembrolizumab, avelumab, and axitinib as in Arm I in the absence of disease progression or unacceptable toxicity. Axitinib should be stopped at least 24 hours prior to surgery.
After completion of trial treatment, patients are followed up every 3 months for the first year, every 6 months for years 2 and 3, and then annually for up to 7 years from randomization.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 364 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Phase III Trial of Immunotherapy-Based Combination Therapy With or Without Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma (PROBE Trial) |
Actual Study Start Date : | March 8, 2021 |
Estimated Primary Completion Date : | July 2033 |
Estimated Study Completion Date : | July 2033 |
Arm | Intervention/treatment |
---|---|
Active Comparator: Arm 1: Continued Systemic Therapy Only
Nivolumab 240 mg IV 1 q 2 weeks OR Nivolumab 480 mg IV 1 q 4 weeks OR Pembrolizumab 200 mg IV 1 q 3 weeks Axitinib 5 mg oral Daily BID OR Avelumab 10 mg/kg IV 1 q 2 weeks Axitinib 5 mg oral Daily BID |
Procedure: Cytoreductive Nephrectomy
Radical or partial nephrectomy may be performed using laparoscopic, open, or robotic approaches. Surgery should be performed within 8 weeks of randomization Drug: Active Comparator Nivolumab 240 mg IV 1 q 2 weeks OR Nivolumab 480 mg IV 1 q 4 weeks OR Pembrolizumab 200 mg IV 1 q 3 weeks Axitinib 5 mg oral Daily BID OR Avelumab 10 mg/kg IV 1 q 2 weeks Axitinib 5 mg oral Daily BID |
Experimental: Arm 2: Nephrectomy and Continued Systemic Therapy
Continued systemic therapy as above, plus: Radical or partial nephrectomy may be performed using laparoscopic, open, or robotic approaches. Surgery should be performed within 8 weeks of randomization. |
Procedure: Cytoreductive Nephrectomy
Radical or partial nephrectomy may be performed using laparoscopic, open, or robotic approaches. Surgery should be performed within 8 weeks of randomization |
- Overall survival [ Time Frame: From date of randomization to date of death due to any cause, assessed up to 7 years. ]Analysis will be intent-to-treat. Evidence suggesting early termination of the trial and a conclusion that the cytoreductive nephrectomy (CN) approach is superior to treatment alone would be if the null hypothesis is rejected at the one-sided 0.005 level. For the second and third interim analyses, the null and alternative hypotheses with respect to survival will be tested, with superiority tested at the one-sided 0.005 level, and futility determined to be met if the (CN versus no CN) hazard ratio is greater than or equal to 1. A proportional hazards model will be fit to estimate the hazard ratio adjusting for the stratification factors as covariates in the model. Will evaluate whether each of the stratification factors are predictive factors of cytoreductive nephrectomy by placing an interaction term corresponding to each stratification factor and treatment arm in the proportional hazards survival model.
- Overall survival in subset who received assigned protocol treatment [ Time Frame: From date of randomization to date of death due to any cause, assessed up to 7 years ]Will be included in the proportional hazards regression model adjusting for stratification factors as covariates.
- Progression-free survival [ Time Frame: From date of randomization to date of first documentation of progression, or death due to any cause, assessed up to 7 years ]A proportional hazards model will be used to compare progression-free survival between arms, adjusting for the stratification factors as covariates.
- Objective response [ Time Frame: Up to 7 years ]Objective response includes all confirmed and unconfirmed partial and complete responses. Baseline will be disease assessment at randomization. Response Evaluation Criteria in Solid Tumors response rates will be evaluated, excluding the primary tumor in the kidney because that disease will be removed in half the participant's post-randomization. Comparison of response rates will be performed using logistic regression with stratification factors as covariates and an indicator for treatment arm.
- Change in maximum diameter of primary tumor [ Time Frame: From the disease assessment just prior to the start of immunotherapy to the week 12 disease assessment ]Descriptive statistics will be provided including stratified results by treatment regimen received. Potential additional analyses may include assessment of the interaction between change in primary tumor and randomized treatment arm. This will be modeled as an interaction term in the proportional hazards survival model.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- STEP 1 REGISTRATION: Participants must have a histologically proven diagnosis of clear cell or non-clear cell renal cell carcinoma. Participants with collecting duct carcinoma histology are not eligible. Participants with multifocal or bilateral tumors are eligible
- STEP 1 REGISTRATION: Participants must have primary tumor in place
-
STEP 1 REGISTRATION: Participants must have the following scans performed, showing clinical evidence of measurable or non-measurable metastatic disease:
- Computed tomography (CT) scan of the chest (can be performed without contrast if CT contrast cannot be given)
- CT of abdomen and pelvis with contrast OR magnetic resonance imaging (MRI) of the abdomen and pelvis with or without contrast
Scans must be performed within the following timeframes:
- Treatment naive participants must have scans documenting metastatic disease completed within 90 days prior to study registration
-
Previously treated participants must have scans documenting metastatic disease completed within 90 days prior to first dose of systemic treatment
- STEP 1 REGISTRATION: Participants with symptomatic metastases may have received palliative radiotherapy or receive palliative radiotherapy after registration
- STEP 1 REGISTRATION: Participants must have no clear contraindications to nephrectomy
- STEP 1 REGISTRATION: Participants must be offered the opportunity to participate in specimen bank. With participant consent, specimens must be collected and submitted via the Southwest Oncology Group (SWOG) Specimen Tracking System
- STEP 1 REGISTRATION: Participants must be informed of the investigational nature of this study and must sign and give informed consent in accordance with institutional and federal guidelines
- STEP 1 REGISTRATION: As part of the Oncology Patient Enrollment Network (OPEN) registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system
- STEP 2 REGISTRATION: Participants must have at least one of the following scans performed 12 weeks (+/- 2 weeks) after starting pre-randomization treatment
- CT scan of the chest (can be performed without contrast if CT contrast cannot be given)
-
CT of abdomen and pelvis with contrast OR MRI of the abdomen and pelvis with or without contrast Scans must be performed within 28 days prior to randomization. Response should be assessed by comparing with a CT or MRI of the chest, abdomen and pelvis obtained prior to starting pre-randomization treatment. Participants with complete response in all metastatic sites are not eligible to randomize to Step 2
• STEP 2 REGISTRATION: Participants must have one of the following objective statuses after 12 weeks of pre-randomization treatment
- Stable disease
- Partial response
-
The treating investigator believes the patient is deriving clinical benefit from systemic therapy AND have Zubrod performance status 0-1
- STEP 2 REGISTRATION: Participants must plan to continue the immune-based therapy received during pre-randomization treatment
- STEP 2 REGISTRATION: Participants must be randomized on or between the 11th and 14th week of protocol-directed pre-randomization treatment therapy
- STEP 2 REGISTRATION: Participants must have received at least one of the minimum amounts of immunotherapy:
- 2 infusions of nivolumab + 1 infusion of ipilimumab
- 2 infusions of pembrolizumab
-
2 infusions of avelumab
- STEP 2 REGISTRATION: Participants must have a planned surgery date within 42 days of randomization
- STEP 2 REGISTRATION: Participants must be a surgical candidate as determined by study urologist. The urology consult should be done within 42 days prior to randomization
- STEP 2 REGISTRATION: Participants must have a complete physical examination and medical history within 28 days prior to randomization
- STEP 2 REGISTRATION: Participants must have a Zubrod performance status of 0-1 within 28 days prior to randomization
- STEP 2 REGISTRATION: Total bilirubin =< institutional upper limit of normal (ULN) (within 28 days prior to randomization)
- STEP 2 REGISTRATION: Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =< 3 x institutional upper limit of normal (ULN) (within 28 days prior to randomization)
- STEP 2 REGISTRATION: Serum creatinine =< 1.5 x the institutional upper limit of normal (IULN) OR measured OR calculated creatinine clearance >= 50 mL/min using the Cockcroft-Gault Formula) (must have been drawn and processed within 28 days prior to randomization)
Exclusion Criteria:
- STEP 1 REGISTRATION: Participants must not have known active brain metastases. Participants with previously treated brain metastases are eligible if participant has no neurologic signs or symptoms suggestive of brain metastasis. Brain imaging studies are not required. If brain imaging studies are performed, they must be negative for disease
-
STEP 1 REGISTRATION: Participants must not have received the following prior treatment of metastatic renal cell carcinoma:
- Treatment naive participants must not have received any prior lines of systemic therapy for metastatic renal cell carcinoma beyond the line intended as part of protocol therapy
- Previously treated participants must not have received any systemic therapy for metastatic renal cell carcinoma beyond the one regimen received off protocol as specified in Step 1 pre-randomization treatment
-
STEP 1 REGISTRATION: Participants must not have received more than the following amounts protocol-directed pre-randomization treatment:
- Treatment naive participants must not have received any pre-randomization treatment.
-
Previously treated participants must not be planning to receive any additional treatment prior to Step 2 randomization, and must not have received more than the following amounts of pre-randomization treatment:
- 4 infusions of nivolumab
- 4 infusions of ipilimumab
- 4 infusions of pembrolizumab
- 7 infusions of avelumab
-
STEP 1 REGISTRATION: Participants must not have received immunotherapy for any cancer within the following timeframes:
- Treatment naive participants must not have received any immunotherapy within a year of registration
- Previously treated participants must not have received any other immunotherapy within a year of the start of off protocol specified pre-randomization treatment
- STEP 1 REGISTRATION: Participants must not have a solitary kidney and not have a transplanted kidney
- STEP 1 REGISTRATION: No other prior malignancy is allowed except for the following: adequately treated basal cell or squamous cell skin cancer, any in situ or T1 cancer, adequately treated stage I or II cancer from which the participant is currently in complete remission, or any other cancer from which the participant has been disease free for at least two years
- STEP 1 REGISTRATION: Participants must not have been previously diagnosed with a medical condition that makes them ineligible for immune based combination therapy or nephrectomy
- STEP 2 REGISTRATION: Participants must not show progression in the primary tumor. Participants who are considered to have pseudo progression are allowed
- STEP 2 REGISTRATION: Participants must not have known active brain metastases. Participants with previously treated brain metastases are eligible if participant has no neurologic signs or symptoms suggestive of brain metastasis. Brain imaging studies are not required. If brain imaging studies are performed, they must be negative for disease
- STEP 2 REGISTRATION: No other prior malignancy is allowed except for the following: adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, adequately treated stage I or II cancer from which the participant is currently in complete remission, or any other cancer from which the participant has been disease free for two years
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04510597
Contact: Megan Keim, MS | 210-614-8808 | mkeim@swog.org | |
Contact: Dana Sparks, MAT | 210-614-8808 ext 1004 | dsparks@swog.org |
United States, Alabama | |
University of Alabama at Birmingham Cancer Center | Recruiting |
Birmingham, Alabama, United States, 35233 | |
Contact: Site Public Contact 205-934-0220 tmyrick@uab.edu | |
Principal Investigator: Arnab Basu | |
United States, Arizona | |
Banner MD Anderson Cancer Center | Recruiting |
Gilbert, Arizona, United States, 85234 | |
Contact: Site Public Contact 602-747-9738 | |
Principal Investigator: Chinedu Mmeje | |
Kingman Regional Medical Center | Recruiting |
Kingman, Arizona, United States, 86401 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Banner University Medical Center - Tucson | Recruiting |
Tucson, Arizona, United States, 85719 | |
Contact: Site Public Contact UACC-IIT@uacc.arizona.edu | |
Principal Investigator: Benjamin R. Lee | |
University of Arizona Cancer Center-North Campus | Recruiting |
Tucson, Arizona, United States, 85719 | |
Contact: Site Public Contact UACC-IIT@uacc.arizona.edu | |
Principal Investigator: Benjamin R. Lee | |
United States, Arkansas | |
Mercy Hospital Fort Smith | Recruiting |
Fort Smith, Arkansas, United States, 72903 | |
Contact: Site Public Contact 800-378-9373 | |
Principal Investigator: Jay W. Carlson | |
United States, California | |
PCR Oncology | Recruiting |
Arroyo Grande, California, United States, 93420 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Sutter Auburn Faith Hospital | Recruiting |
Auburn, California, United States, 95602 | |
Contact: Site Public Contact Melanie.Cook@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
Sutter Cancer Centers Radiation Oncology Services-Auburn | Recruiting |
Auburn, California, United States, 95603 | |
Contact: Site Public Contact Melanie.Cook@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
Alta Bates Summit Medical Center-Herrick Campus | Recruiting |
Berkeley, California, United States, 94704 | |
Contact: Site Public Contact Melanie.Cook@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
Keck Medicine of USC Buena Park | Recruiting |
Buena Park, California, United States, 90621 | |
Contact: Site Public Contact 714-522-0908 | |
Principal Investigator: Varsha Tulpule | |
Sutter Cancer Centers Radiation Oncology Services-Cameron Park | Recruiting |
Cameron Park, California, United States, 95682 | |
Contact: Site Public Contact Melanie.Cook@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
Eden Hospital Medical Center | Recruiting |
Castro Valley, California, United States, 94546 | |
Contact: Site Public Contact Melanie.Cook@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
Sutter Davis Hospital | Recruiting |
Davis, California, United States, 95616 | |
Contact: Site Public Contact Melanie.Cook@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
City of Hope Comprehensive Cancer Center | Recruiting |
Duarte, California, United States, 91010 | |
Contact: Site Public Contact 800-826-4673 becomingapatient@coh.org | |
Principal Investigator: Abhishek Tripathi | |
Palo Alto Medical Foundation-Fremont | Recruiting |
Fremont, California, United States, 94538 | |
Contact: Site Public Contact Melanie.Cook@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
Keck Medicine of USC Huntington Beach | Recruiting |
Huntington Beach, California, United States, 92648 | |
Contact: Site Public Contact 714-861-1000 karenn@pacshoresoncology.com | |
Principal Investigator: Varsha Tulpule | |
Keck Medicine of USC Koreatown | Recruiting |
Los Angeles, California, United States, 90020 | |
Contact: Site Public Contact 213-388-0908 | |
Principal Investigator: Varsha Tulpule | |
Los Angeles County-USC Medical Center | Recruiting |
Los Angeles, California, United States, 90033 | |
Contact: Site Public Contact 323-865-0451 | |
Principal Investigator: Varsha Tulpule | |
USC / Norris Comprehensive Cancer Center | Recruiting |
Los Angeles, California, United States, 90033 | |
Contact: Site Public Contact 323-865-0451 | |
Principal Investigator: Varsha Tulpule | |
Cedars Sinai Medical Center | Recruiting |
Los Angeles, California, United States, 90048 | |
Contact: Site Public Contact 310-423-8965 | |
Principal Investigator: Hyung L. Kim | |
UCLA / Jonsson Comprehensive Cancer Center | Recruiting |
Los Angeles, California, United States, 90095 | |
Contact: Site Public Contact 888-798-0719 | |
Principal Investigator: Brian Shuch | |
Memorial Medical Center | Recruiting |
Modesto, California, United States, 95355 | |
Contact: Site Public Contact Melanie.Cook@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
Palo Alto Medical Foundation-Camino Division | Recruiting |
Mountain View, California, United States, 94040 | |
Contact: Site Public Contact Melanie.Cook@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
Palo Alto Medical Foundation-Gynecologic Oncology | Recruiting |
Mountain View, California, United States, 94040 | |
Contact: Site Public Contact Melanie.Cook@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
USC Norris Oncology/Hematology-Newport Beach | Recruiting |
Newport Beach, California, United States, 92663 | |
Contact: Site Public Contact 323-865-0451 | |
Principal Investigator: Varsha Tulpule | |
Sutter Cancer Research Consortium | Recruiting |
Novato, California, United States, 94945 | |
Contact: Site Public Contact Melanie.Cook@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
Palo Alto Medical Foundation Health Care | Recruiting |
Palo Alto, California, United States, 94301 | |
Contact: Site Public Contact Melanie.Cook@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
Keck Medical Center of USC Pasadena | Recruiting |
Pasadena, California, United States, 91105 | |
Contact: Site Public Contact 323-865-0451 | |
Principal Investigator: Varsha Tulpule | |
Sutter Cancer Centers Radiation Oncology Services-Roseville | Recruiting |
Roseville, California, United States, 95661 | |
Contact: Site Public Contact Melanie.Cook@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
Sutter Roseville Medical Center | Recruiting |
Roseville, California, United States, 95661 | |
Contact: Site Public Contact Melanie.Cook@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
Sutter Medical Center Sacramento | Recruiting |
Sacramento, California, United States, 95816 | |
Contact: Site Public Contact Melanie.Cook@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
University of California Davis Comprehensive Cancer Center | Recruiting |
Sacramento, California, United States, 95817 | |
Contact: Site Public Contact 916-734-3089 | |
Principal Investigator: Shuchi Gulati | |
California Pacific Medical Center-Pacific Campus | Recruiting |
San Francisco, California, United States, 94115 | |
Contact: Site Public Contact Melanie.Cook@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
Mills Health Center | Recruiting |
San Mateo, California, United States, 94401 | |
Contact: Site Public Contact protocols@swog.org | |
Principal Investigator: Ari D. Baron | |
Palo Alto Medical Foundation-Santa Cruz | Recruiting |
Santa Cruz, California, United States, 95065 | |
Contact: Site Public Contact 415-209-2683 hempell@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
Sutter Pacific Medical Foundation | Recruiting |
Santa Rosa, California, United States, 95403 | |
Contact: Site Public Contact 415-209-2683 hempell@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
City of Hope South Pasadena | Recruiting |
South Pasadena, California, United States, 91030 | |
Contact: Site Public Contact 800-826-4673 becomingapatient@coh.org | |
Principal Investigator: Abhishek Tripathi | |
Palo Alto Medical Foundation-Sunnyvale | Recruiting |
Sunnyvale, California, United States, 94086 | |
Contact: Site Public Contact Melanie.Cook@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
Cedars-Sinai Cancer - Tarzana | Recruiting |
Tarzana, California, United States, 91356 | |
Contact: Site Public Contact 818-981-3818 | |
Principal Investigator: Hyung L. Kim | |
City of Hope Upland | Recruiting |
Upland, California, United States, 91786 | |
Contact: Site Public Contact 800-826-4673 becomingapatient@coh.org | |
Principal Investigator: Abhishek Tripathi | |
Sutter Cancer Centers Radiation Oncology Services-Vacaville | Recruiting |
Vacaville, California, United States, 95687 | |
Contact: Site Public Contact 415-209-2683 hempell@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
Sutter Solano Medical Center/Cancer Center | Recruiting |
Vallejo, California, United States, 94589 | |
Contact: Site Public Contact Melanie.Cook@sutterhealth.org | |
Principal Investigator: Ari D. Baron | |
United States, District of Columbia | |
MedStar Washington Hospital Center | Recruiting |
Washington, District of Columbia, United States, 20010 | |
Contact: Site Public Contact 202-877-8839 | |
Principal Investigator: Suthee Rapisuwon | |
United States, Florida | |
AdventHealth Altamonte | Recruiting |
Altamonte Springs, Florida, United States, 32701 | |
Contact: Site Public Contact 407-303-2200 | |
Principal Investigator: Carlos A. Alemany | |
AdventHealth Celebration | Recruiting |
Celebration, Florida, United States, 34747 | |
Contact: Site Public Contact 407-303-4120 | |
Principal Investigator: Carlos A. Alemany | |
AdventHealth Kissimmee | Recruiting |
Kissimmee, Florida, United States, 34744 | |
Contact: Site Public Contact 407-846-4343 | |
Principal Investigator: Carlos A. Alemany | |
AdventHealth Medical Group Urology at Orlando | Recruiting |
Orlando, Florida, United States, 32803 | |
Contact: Site Public Contact 407-897-3499 | |
Principal Investigator: Carlos A. Alemany | |
AdventHealth Orlando | Recruiting |
Orlando, Florida, United States, 32803 | |
Contact: Site Public Contact 407-303-2090 FH.Cancer.Research@flhosp.org | |
Principal Investigator: Carlos A. Alemany | |
Orlando Health Cancer Institute | Recruiting |
Orlando, Florida, United States, 32806 | |
Contact: Site Public Contact 321-841-7246 CancerClinicalTrials@orlandohealth.com | |
Principal Investigator: Daniel Landau | |
AdventHealth East Orlando | Recruiting |
Orlando, Florida, United States, 32822 | |
Contact: Site Public Contact 407-303-8110 | |
Principal Investigator: Carlos A. Alemany | |
AdventHealth Winter Park | Recruiting |
Winter Park, Florida, United States, 32792 | |
Contact: Site Public Contact 407-646-7000 | |
Principal Investigator: Carlos A. Alemany | |
United States, Illinois | |
Saint Anthony's Health | Recruiting |
Alton, Illinois, United States, 62002 | |
Contact: Site Public Contact 618-463-5623 | |
Principal Investigator: Jay W. Carlson | |
Rush - Copley Medical Center | Recruiting |
Aurora, Illinois, United States, 60504 | |
Contact: Site Public Contact 630-978-6212 Cancer.Research@rushcopley.com | |
Principal Investigator: Priyank P. Patel | |
Advocate Good Shepherd Hospital | Recruiting |
Barrington, Illinois, United States, 60010 | |
Contact: Site Public Contact 847-842-4847 | |
Principal Investigator: Adam P. Siegel | |
Illinois CancerCare-Bloomington | Recruiting |
Bloomington, Illinois, United States, 61704 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Loyola Center for Health at Burr Ridge | Recruiting |
Burr Ridge, Illinois, United States, 60527 | |
Contact: Site Public Contact 708-216-9000 | |
Principal Investigator: Joseph I. Clark | |
Illinois CancerCare-Canton | Recruiting |
Canton, Illinois, United States, 61520 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Memorial Hospital of Carbondale | Recruiting |
Carbondale, Illinois, United States, 62902 | |
Contact: Site Public Contact 618-457-5200 clinical.research@sih.net | |
Principal Investigator: Bryan A. Faller | |
SIH Cancer Institute | Recruiting |
Carterville, Illinois, United States, 62918 | |
Contact: Site Public Contact 618-985-3333 clinical.research@sih.net | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Carthage | Recruiting |
Carthage, Illinois, United States, 62321 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Centralia Oncology Clinic | Recruiting |
Centralia, Illinois, United States, 62801 | |
Contact: Site Public Contact 217-876-4762 morganthaler.jodi@mhsil.com | |
Principal Investigator: Bryan A. Faller | |
Saint Mary's Hospital | Recruiting |
Centralia, Illinois, United States, 62801 | |
Contact: Site Public Contact protocols@swog.org | |
Principal Investigator: Jay W. Carlson | |
Northwestern University | Recruiting |
Chicago, Illinois, United States, 60611 | |
Contact: Site Public Contact 312-695-1301 cancer@northwestern.edu | |
Principal Investigator: Jeffrey A. Sosman | |
Rush University Medical Center | Recruiting |
Chicago, Illinois, United States, 60612 | |
Contact: Site Public Contact 312-942-5498 clinical_trials@rush.edu | |
Principal Investigator: Alan Tan | |
University of Illinois | Recruiting |
Chicago, Illinois, United States, 60612 | |
Contact: Site Public Contact 312-355-3046 | |
Principal Investigator: Daniel Moreira | |
University of Chicago Comprehensive Cancer Center | Active, not recruiting |
Chicago, Illinois, United States, 60637 | |
Advocate Illinois Masonic Medical Center | Recruiting |
Chicago, Illinois, United States, 60657 | |
Contact: Site Public Contact 773-296-5360 | |
Principal Investigator: Adam P. Siegel | |
AMG Crystal Lake - Oncology | Recruiting |
Crystal Lake, Illinois, United States, 60014 | |
Contact: Site Public Contact 630-929-6129 advocateresearch@advocate.com | |
Principal Investigator: Adam P. Siegel | |
Carle at The Riverfront | Recruiting |
Danville, Illinois, United States, 61832 | |
Contact: Site Public Contact 800-446-5532 Research@Carle.com | |
Principal Investigator: Priyank P. Patel | |
Cancer Care Specialists of Illinois - Decatur | Recruiting |
Decatur, Illinois, United States, 62526 | |
Contact: Site Public Contact 217-876-4762 morganthaler.jodi@mhsil.com | |
Principal Investigator: Bryan A. Faller | |
Decatur Memorial Hospital | Recruiting |
Decatur, Illinois, United States, 62526 | |
Contact: Site Public Contact 217-876-4762 morganthaler.jodi@mhsil.com | |
Principal Investigator: Bryan A. Faller | |
Northwestern Medicine Cancer Center Kishwaukee | Recruiting |
DeKalb, Illinois, United States, 60115 | |
Contact: Site Public Contact 630-352-5360 Donald.Smith3@nm.org | |
Principal Investigator: Jeffrey A. Sosman | |
Illinois CancerCare-Dixon | Recruiting |
Dixon, Illinois, United States, 61021 | |
Contact: Site Public Contact 815-285-7800 | |
Principal Investigator: Bryan A. Faller | |
Advocate Good Samaritan Hospital | Recruiting |
Downers Grove, Illinois, United States, 60515 | |
Contact: Site Public Contact 630-275-1270 Barbara.barhamand@advocatehealth.com | |
Principal Investigator: Adam P. Siegel | |
Carle Physician Group-Effingham | Recruiting |
Effingham, Illinois, United States, 62401 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Priyank P. Patel | |
Crossroads Cancer Center | Recruiting |
Effingham, Illinois, United States, 62401 | |
Contact: Site Public Contact 217-876-4762 morganthaler.jodi@mhsil.com | |
Principal Investigator: Bryan A. Faller | |
Advocate Sherman Hospital | Recruiting |
Elgin, Illinois, United States, 60123 | |
Contact: Site Public Contact 847-429-2907 | |
Principal Investigator: Adam P. Siegel | |
Elmhurst Memorial Hospital | Recruiting |
Elmhurst, Illinois, United States, 60126 | |
Contact: Site Public Contact 630-758-5460 Jrohde@emhc.org | |
Principal Investigator: Brian C. Myre | |
Illinois CancerCare-Eureka | Recruiting |
Eureka, Illinois, United States, 61530 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Galesburg | Recruiting |
Galesburg, Illinois, United States, 61401 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Western Illinois Cancer Treatment Center | Recruiting |
Galesburg, Illinois, United States, 61401 | |
Contact: Site Public Contact 309-344-2831 | |
Principal Investigator: Bryan A. Faller | |
Northwestern Medicine Cancer Center Delnor | Recruiting |
Geneva, Illinois, United States, 60134 | |
Contact: Site Public Contact 630-352-5360 Donald.Smith3@nm.org | |
Principal Investigator: Jeffrey A. Sosman | |
Advocate South Suburban Hospital | Recruiting |
Hazel Crest, Illinois, United States, 60429 | |
Contact: Site Public Contact 708-799-9995 | |
Principal Investigator: Adam P. Siegel | |
Loyola Medicine Homer Glen | Recruiting |
Homer Glen, Illinois, United States, 60491 | |
Contact: Site Public Contact 708-216-9000 | |
Principal Investigator: Joseph I. Clark | |
Illinois CancerCare-Kewanee Clinic | Recruiting |
Kewanee, Illinois, United States, 61443 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Northwestern Medicine Lake Forest Hospital | Recruiting |
Lake Forest, Illinois, United States, 60045 | |
Contact: Site Public Contact cancertrials@northwestern.edu | |
Principal Investigator: Jeffrey A. Sosman | |
AMG Libertyville - Oncology | Recruiting |
Libertyville, Illinois, United States, 60048 | |
Contact: Site Public Contact 630-929-6129 advocateresearch@advocatehealth.com | |
Principal Investigator: Adam P. Siegel | |
Condell Memorial Hospital | Recruiting |
Libertyville, Illinois, United States, 60048 | |
Contact: Site Public Contact 630-929-6129 advocateresearch@advocatehealth.com | |
Principal Investigator: Adam P. Siegel | |
Illinois CancerCare-Macomb | Recruiting |
Macomb, Illinois, United States, 61455 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Carle Physician Group-Mattoon/Charleston | Recruiting |
Mattoon, Illinois, United States, 61938 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Priyank P. Patel | |
Loyola University Medical Center | Recruiting |
Maywood, Illinois, United States, 60153 | |
Contact: Site Public Contact 708-226-4357 | |
Principal Investigator: Joseph I. Clark | |
Marjorie Weinberg Cancer Center at Loyola-Gottlieb | Recruiting |
Melrose Park, Illinois, United States, 60160 | |
Contact: Site Public Contact 708-450-4554 | |
Principal Investigator: Joseph I. Clark | |
Good Samaritan Regional Health Center | Recruiting |
Mount Vernon, Illinois, United States, 62864 | |
Contact: Site Public Contact 618-242-4600 | |
Principal Investigator: Jay W. Carlson | |
Edward Hospital/Cancer Center | Recruiting |
Naperville, Illinois, United States, 60540 | |
Contact: Site Public Contact 630-646-6075 | |
Principal Investigator: Brian C. Myre | |
UC Comprehensive Cancer Center at Silver Cross | Active, not recruiting |
New Lenox, Illinois, United States, 60451 | |
Cancer Care Center of O'Fallon | Recruiting |
O'Fallon, Illinois, United States, 62269 | |
Contact: Site Public Contact 217-876-4762 morganthaler.jodi@mhsil.com | |
Principal Investigator: Bryan A. Faller | |
Advocate Christ Medical Center | Recruiting |
Oak Lawn, Illinois, United States, 60453-2699 | |
Contact: Site Public Contact 800-323-8622 | |
Principal Investigator: Adam P. Siegel | |
University of Chicago Medicine-Orland Park | Active, not recruiting |
Orland Park, Illinois, United States, 60462 | |
Illinois CancerCare-Ottawa Clinic | Recruiting |
Ottawa, Illinois, United States, 61350 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Advocate Lutheran General Hospital | Recruiting |
Park Ridge, Illinois, United States, 60068 | |
Contact: Site Public Contact 847-384-3621 | |
Principal Investigator: Adam P. Siegel | |
Illinois CancerCare-Pekin | Recruiting |
Pekin, Illinois, United States, 61554 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Peoria | Recruiting |
Peoria, Illinois, United States, 61615 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Methodist Medical Center of Illinois | Recruiting |
Peoria, Illinois, United States, 61636 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Peru | Recruiting |
Peru, Illinois, United States, 61354 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Valley Radiation Oncology | Recruiting |
Peru, Illinois, United States, 61354 | |
Contact: Site Public Contact 815-664-4141 | |
Principal Investigator: Bryan A. Faller | |
Edward Hospital/Cancer Center?Plainfield | Recruiting |
Plainfield, Illinois, United States, 60585 | |
Contact: Site Public Contact 630-646-6075 Cancerresearch@edward.org | |
Principal Investigator: Brian C. Myre | |
Illinois CancerCare-Princeton | Recruiting |
Princeton, Illinois, United States, 61356 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Southern Illinois University School of Medicine | Recruiting |
Springfield, Illinois, United States, 62702 | |
Contact: Site Public Contact 217-545-7929 | |
Principal Investigator: Bryan A. Faller | |
Springfield Clinic | Recruiting |
Springfield, Illinois, United States, 62702 | |
Contact: Site Public Contact 800-444-7541 | |
Principal Investigator: Bryan A. Faller | |
Memorial Medical Center | Recruiting |
Springfield, Illinois, United States, 62781 | |
Contact: Site Public Contact 217-528-7541 pallante.beth@mhsil.com | |
Principal Investigator: Bryan A. Faller | |
Carle Cancer Center | Recruiting |
Urbana, Illinois, United States, 61801 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Priyank P. Patel | |
The Carle Foundation Hospital | Recruiting |
Urbana, Illinois, United States, 61801 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Priyank P. Patel | |
Northwestern Medicine Cancer Center Warrenville | Recruiting |
Warrenville, Illinois, United States, 60555 | |
Contact: Site Public Contact 630-352-5360 Donald.Smith3@nm.org | |
Principal Investigator: Jeffrey A. Sosman | |
Illinois CancerCare - Washington | Recruiting |
Washington, Illinois, United States, 61571 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Rush-Copley Healthcare Center | Recruiting |
Yorkville, Illinois, United States, 60560 | |
Contact: Site Public Contact 630-978-6212 Cancer.Research@rushcopley.com | |
Principal Investigator: Priyank P. Patel | |
United States, Indiana | |
Reid Health | Recruiting |
Richmond, Indiana, United States, 47374 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
United States, Iowa | |
Mary Greeley Medical Center | Recruiting |
Ames, Iowa, United States, 50010 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Joseph J. Merchant | |
McFarland Clinic - Ames | Recruiting |
Ames, Iowa, United States, 50010 | |
Contact: Site Public Contact 515-239-4734 ksoder@mcfarlandclinic.com | |
Principal Investigator: Joseph J. Merchant | |
McFarland Clinic - Boone | Recruiting |
Boone, Iowa, United States, 50036 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Joseph J. Merchant | |
Saint Anthony Regional Hospital | Active, not recruiting |
Carroll, Iowa, United States, 51401 | |
Iowa Methodist Medical Center | Active, not recruiting |
Des Moines, Iowa, United States, 50309 | |
Medical Oncology and Hematology Associates-Des Moines | Active, not recruiting |
Des Moines, Iowa, United States, 50309 | |
Broadlawns Medical Center | Active, not recruiting |
Des Moines, Iowa, United States, 50314 | |
Iowa Lutheran Hospital | Active, not recruiting |
Des Moines, Iowa, United States, 50316 | |
McFarland Clinic - Trinity Cancer Center | Recruiting |
Fort Dodge, Iowa, United States, 50501 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Joseph J. Merchant | |
Trinity Regional Medical Center | Active, not recruiting |
Fort Dodge, Iowa, United States, 50501 | |
McFarland Clinic - Jefferson | Recruiting |
Jefferson, Iowa, United States, 50129 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Joseph J. Merchant | |
McFarland Clinic - Marshalltown | Recruiting |
Marshalltown, Iowa, United States, 50158 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Joseph J. Merchant | |
Methodist West Hospital | Active, not recruiting |
West Des Moines, Iowa, United States, 50266-7700 | |
United States, Kansas | |
Central Care Cancer Center - Garden City | Recruiting |
Garden City, Kansas, United States, 67846 | |
Contact: Site Public Contact 913-948-5588 aroland@kccop.org | |
Principal Investigator: Jay W. Carlson | |
Central Care Cancer Center - Great Bend | Recruiting |
Great Bend, Kansas, United States, 67530 | |
Contact: Site Public Contact 913-948-5588 aroland@kccop.org | |
Principal Investigator: Jay W. Carlson | |
United States, Kentucky | |
University of Kentucky/Markey Cancer Center | Recruiting |
Lexington, Kentucky, United States, 40536 | |
Contact: Site Public Contact 859-257-3379 | |
Principal Investigator: Zin W. Myint | |
United States, Louisiana | |
Hematology/Oncology Clinic PLLC | Suspended |
Baton Rouge, Louisiana, United States, 70809 | |
East Jefferson General Hospital | Recruiting |
Metairie, Louisiana, United States, 70006 | |
Contact: Site Public Contact 504-210-3539 emede1@lsuhsc.edu | |
Principal Investigator: Jessie R. Gills | |
LSU Healthcare Network / Metairie Multi-Specialty Clinic | Recruiting |
Metairie, Louisiana, United States, 70006 | |
Contact: Site Public Contact 504-210-3539 emede1@lsuhsc.edu | |
Principal Investigator: Jessie R. Gills | |
Louisiana State University Health Science Center | Recruiting |
New Orleans, Louisiana, United States, 70112 | |
Contact: Site Public Contact 504-210-3539 emede1@lsuhsc.edu | |
Principal Investigator: Jessie R. Gills | |
Tulane University Health Sciences Center | Recruiting |
New Orleans, Louisiana, United States, 70112 | |
Contact: Site Public Contact 504-988-6121 | |
Principal Investigator: Mark Sides | |
University Medical Center New Orleans | Recruiting |
New Orleans, Louisiana, United States, 70112 | |
Contact: Site Public Contact 504-210-3539 emede1@lsuhsc.edu | |
Principal Investigator: Jessie R. Gills | |
United States, Michigan | |
University of Michigan Comprehensive Cancer Center | Recruiting |
Ann Arbor, Michigan, United States, 48109 | |
Contact: Site Public Contact 800-865-1125 | |
Principal Investigator: Ulka N. Vaishampayan | |
Bronson Battle Creek | Recruiting |
Battle Creek, Michigan, United States, 49017 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
University of Michigan - Brighton Center for Specialty Care | Recruiting |
Brighton, Michigan, United States, 48116 | |
Contact: Site Public Contact 800-865-1125 | |
Principal Investigator: Ulka N. Vaishampayan | |
Henry Ford Cancer Institute-Downriver | Active, not recruiting |
Brownstown, Michigan, United States, 48183 | |
Henry Ford Hematology Oncology - Hayes | Active, not recruiting |
Clinton Township, Michigan, United States, 48038 | |
Henry Ford Macomb Hospital-Clinton Township | Active, not recruiting |
Clinton Township, Michigan, United States, 48038 | |
Henry Ford Medical Center-Fairlane | Active, not recruiting |
Dearborn, Michigan, United States, 48126 | |
Henry Ford Hospital | Active, not recruiting |
Detroit, Michigan, United States, 48202 | |
Helen DeVos Children's Hospital at Spectrum Health | Recruiting |
Grand Rapids, Michigan, United States, 49503 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Spectrum Health at Butterworth Campus | Recruiting |
Grand Rapids, Michigan, United States, 49503 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Trinity Health Grand Rapids Hospital | Recruiting |
Grand Rapids, Michigan, United States, 49503 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Allegiance Health | Active, not recruiting |
Jackson, Michigan, United States, 49201 | |
Bronson Methodist Hospital | Recruiting |
Kalamazoo, Michigan, United States, 49007 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
West Michigan Cancer Center | Recruiting |
Kalamazoo, Michigan, United States, 49007 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Ascension Borgess Cancer Center | Recruiting |
Kalamazoo, Michigan, United States, 49009 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Borgess Medical Center | Recruiting |
Kalamazoo, Michigan, United States, 49048 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Trinity Health Muskegon Hospital | Recruiting |
Muskegon, Michigan, United States, 49444 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Lakeland Hospital Niles | Recruiting |
Niles, Michigan, United States, 49120 | |
Contact: Site Public Contact 616-391-1230 | |
Principal Investigator: Kathleen J. Yost | |
Cancer and Hematology Centers of Western Michigan - Norton Shores | Recruiting |
Norton Shores, Michigan, United States, 49444 | |
Contact: Site Public Contact 616-391-1230 connie.szczepanek@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Henry Ford Medical Center-Columbus | Active, not recruiting |
Novi, Michigan, United States, 48377 | |
Spectrum Health Reed City Hospital | Recruiting |
Reed City, Michigan, United States, 49677 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Lakeland Medical Center Saint Joseph | Recruiting |
Saint Joseph, Michigan, United States, 49085 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Marie Yeager Cancer Center | Recruiting |
Saint Joseph, Michigan, United States, 49085 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Henry Ford Macomb Health Center - Shelby Township | Suspended |
Shelby, Michigan, United States, 48315 | |
Munson Medical Center | Recruiting |
Traverse City, Michigan, United States, 49684 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Henry Ford West Bloomfield Hospital | Active, not recruiting |
West Bloomfield, Michigan, United States, 48322 | |
Henry Ford Wyandotte Hospital | Active, not recruiting |
Wyandotte, Michigan, United States, 48192 | |
University of Michigan Health - West | Recruiting |
Wyoming, Michigan, United States, 49519 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
United States, Minnesota | |
Fairview Ridges Hospital | Suspended |
Burnsville, Minnesota, United States, 55337 | |
Minnesota Oncology - Burnsville | Recruiting |
Burnsville, Minnesota, United States, 55337 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Cambridge Medical Center | Recruiting |
Cambridge, Minnesota, United States, 55008 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Mercy Hospital | Recruiting |
Coon Rapids, Minnesota, United States, 55433 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Fairview Southdale Hospital | Recruiting |
Edina, Minnesota, United States, 55435 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Unity Hospital | Recruiting |
Fridley, Minnesota, United States, 55432 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Fairview Clinics and Surgery Center Maple Grove | Recruiting |
Maple Grove, Minnesota, United States, 55369 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Minnesota Oncology Hematology PA-Maplewood | Recruiting |
Maplewood, Minnesota, United States, 55109 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Saint John's Hospital - Healtheast | Recruiting |
Maplewood, Minnesota, United States, 55109 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Abbott-Northwestern Hospital | Recruiting |
Minneapolis, Minnesota, United States, 55407 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Hennepin County Medical Center | Recruiting |
Minneapolis, Minnesota, United States, 55415 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Health Partners Inc | Recruiting |
Minneapolis, Minnesota, United States, 55454 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Monticello Cancer Center | Recruiting |
Monticello, Minnesota, United States, 55362 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
New Ulm Medical Center | Recruiting |
New Ulm, Minnesota, United States, 56073 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Fairview Northland Medical Center | Recruiting |
Princeton, Minnesota, United States, 55371 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
North Memorial Medical Health Center | Recruiting |
Robbinsdale, Minnesota, United States, 55422 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Park Nicollet Clinic - Saint Louis Park | Recruiting |
Saint Louis Park, Minnesota, United States, 55416 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Regions Hospital | Recruiting |
Saint Paul, Minnesota, United States, 55101 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
United Hospital | Recruiting |
Saint Paul, Minnesota, United States, 55102 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Saint Francis Regional Medical Center | Recruiting |
Shakopee, Minnesota, United States, 55379 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Lakeview Hospital | Recruiting |
Stillwater, Minnesota, United States, 55082 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Ridgeview Medical Center | Recruiting |
Waconia, Minnesota, United States, 55387 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Rice Memorial Hospital | Recruiting |
Willmar, Minnesota, United States, 56201 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Minnesota Oncology Hematology PA-Woodbury | Recruiting |
Woodbury, Minnesota, United States, 55125 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Fairview Lakes Medical Center | Recruiting |
Wyoming, Minnesota, United States, 55092 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
United States, Mississippi | |
Gulfport Memorial Hospital | Recruiting |
Gulfport, Mississippi, United States, 39502 | |
Contact: Site Public Contact 504-210-3539 emede1@lsuhsc.edu | |
Principal Investigator: Jessie R. Gills | |
United States, Missouri | |
Saint Louis Cancer and Breast Institute-Ballwin | Recruiting |
Ballwin, Missouri, United States, 63011 | |
Contact: Site Public Contact 314-251-7058 | |
Principal Investigator: Jay W. Carlson | |
Central Care Cancer Center - Bolivar | Recruiting |
Bolivar, Missouri, United States, 65613 | |
Contact: Site Public Contact 913-948-5588 aroland@kccop.org | |
Principal Investigator: Jay W. Carlson | |
Cox Cancer Center Branson | Recruiting |
Branson, Missouri, United States, 65616 | |
Contact: Site Public Contact 417-269-4520 | |
Principal Investigator: Jay W. Carlson | |
Saint Francis Medical Center | Recruiting |
Cape Girardeau, Missouri, United States, 63703 | |
Contact: Site Public Contact 573-334-2230 sfmc@sfmc.net | |
Principal Investigator: Bryan A. Faller | |
Southeast Cancer Center | Recruiting |
Cape Girardeau, Missouri, United States, 63703 | |
Contact: Site Public Contact 573-651-5550 | |
Principal Investigator: Bryan A. Faller | |
Parkland Health Center - Farmington | Recruiting |
Farmington, Missouri, United States, 63640 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Capital Region Southwest Campus | Recruiting |
Jefferson City, Missouri, United States, 65109 | |
Contact: Site Public Contact 573-632-4814 swooden@mail.crmc.org | |
Principal Investigator: Bryan A. Faller | |
Freeman Health System | Recruiting |
Joplin, Missouri, United States, 64804 | |
Contact: Site Public Contact 417-347-4030 LJCrockett@freemanhealth.com | |
Principal Investigator: Jay W. Carlson | |
Mercy Hospital Joplin | Recruiting |
Joplin, Missouri, United States, 64804 | |
Contact: Site Public Contact 417-556-3074 esmeralda.carrillo@mercy.net | |
Principal Investigator: Jay W. Carlson | |
Delbert Day Cancer Institute at PCRMC | Recruiting |
Rolla, Missouri, United States, 65401 | |
Contact: Site Public Contact 573-458-7504 research@phelpshealth.org | |
Principal Investigator: Jay W. Carlson | |
Mercy Clinic-Rolla-Cancer and Hematology | Recruiting |
Rolla, Missouri, United States, 65401 | |
Contact: Site Public Contact 573-458-6379 | |
Principal Investigator: Jay W. Carlson | |
Heartland Regional Medical Center | Recruiting |
Saint Joseph, Missouri, United States, 64506 | |
Contact: Site Public Contact 816-271-7937 linda.schumacher@mymlc.com | |
Principal Investigator: Jay W. Carlson | |
Saint Louis Cancer and Breast Institute-South City | Recruiting |
Saint Louis, Missouri, United States, 63109 | |
Contact: Site Public Contact 314-353-1870 | |
Principal Investigator: Jay W. Carlson | |
Mercy Hospital South | Recruiting |
Saint Louis, Missouri, United States, 63128 | |
Contact: Site Public Contact janet.lesko@mercy.net | |
Principal Investigator: Jay W. Carlson | |
Missouri Baptist Medical Center | Recruiting |
Saint Louis, Missouri, United States, 63131 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Mercy Hospital Saint Louis | Recruiting |
Saint Louis, Missouri, United States, 63141 | |
Contact: Site Public Contact 314-251-7066 | |
Principal Investigator: Jay W. Carlson | |
Sainte Genevieve County Memorial Hospital | Recruiting |
Sainte Genevieve, Missouri, United States, 63670 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Mercy Hospital Springfield | Recruiting |
Springfield, Missouri, United States, 65804 | |
Contact: Site Public Contact 417-269-4520 | |
Principal Investigator: Jay W. Carlson | |
CoxHealth South Hospital | Recruiting |
Springfield, Missouri, United States, 65807 | |
Contact: Site Public Contact 417-269-4520 | |
Principal Investigator: Jay W. Carlson | |
Missouri Baptist Sullivan Hospital | Recruiting |
Sullivan, Missouri, United States, 63080 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Missouri Baptist Outpatient Center-Sunset Hills | Recruiting |
Sunset Hills, Missouri, United States, 63127 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Mercy Hospital Washington | Recruiting |
Washington, Missouri, United States, 63090 | |
Contact: Site Public Contact 636-390-1600 | |
Principal Investigator: Jay W. Carlson | |
United States, Nebraska | |
Nebraska Cancer Specialists/Oncology Hematology West PC - MECC | Recruiting |
Omaha, Nebraska, United States, 68114 | |
Contact: Site Public Contact 402-334-4773 | |
Principal Investigator: Ralph J. Hauke | |
Nebraska Methodist Hospital | Recruiting |
Omaha, Nebraska, United States, 68114 | |
Contact: Site Public Contact 402-354-5144 | |
Principal Investigator: Ralph J. Hauke | |
Oncology Associates PC | Recruiting |
Omaha, Nebraska, United States, 68114 | |
Contact: Site Public Contact 402-354-5860 info@oa-oc.com | |
Principal Investigator: Ralph J. Hauke | |
United States, Nevada | |
Carson Tahoe Regional Medical Center | Recruiting |
Carson City, Nevada, United States, 89703 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Cancer and Blood Specialists-Henderson | Recruiting |
Henderson, Nevada, United States, 89052 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada - Henderson | Recruiting |
Henderson, Nevada, United States, 89052 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada-Horizon Ridge | Recruiting |
Henderson, Nevada, United States, 89052 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Cancer Center-Henderson | Suspended |
Henderson, Nevada, United States, 89052 | |
OptumCare Cancer Care at Seven Hills | Recruiting |
Henderson, Nevada, United States, 89052 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada-Southeast Henderson | Recruiting |
Henderson, Nevada, United States, 89074 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
GenesisCare USA - Henderson | Recruiting |
Henderson, Nevada, United States, 89074 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Urology - Green Valley | Recruiting |
Henderson, Nevada, United States, 89074 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Urology - Pebble | Recruiting |
Henderson, Nevada, United States, 89074 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Urology Specialists of Nevada - Green Valley | Recruiting |
Henderson, Nevada, United States, 89074 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Urology - Pecos | Recruiting |
Las Vegas, Nevada, United States, 89074 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Desert West Surgery | Suspended |
Las Vegas, Nevada, United States, 89102 | |
OptumCare Cancer Care at Charleston | Recruiting |
Las Vegas, Nevada, United States, 89102 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
University Medical Center of Southern Nevada | Recruiting |
Las Vegas, Nevada, United States, 89102 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Hope Cancer Care of Nevada | Recruiting |
Las Vegas, Nevada, United States, 89103 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Radiation Oncology Centers of Nevada Central | Recruiting |
Las Vegas, Nevada, United States, 89106 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Urology Specialists of Nevada - Central | Recruiting |
Las Vegas, Nevada, United States, 89106 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
GenesisCare USA - Las Vegas | Recruiting |
Las Vegas, Nevada, United States, 89109 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Sunrise Hospital and Medical Center | Recruiting |
Las Vegas, Nevada, United States, 89109 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Prostate Cancer Center | Recruiting |
Las Vegas, Nevada, United States, 89113 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Urology - Sunset | Recruiting |
Las Vegas, Nevada, United States, 89113 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Urology Specialists of Nevada - Southwest | Recruiting |
Las Vegas, Nevada, United States, 89113 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Radiation Oncology Centers of Nevada Southeast | Recruiting |
Las Vegas, Nevada, United States, 89119 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Ann M Wierman MD LTD | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada - Northwest | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
GenesisCare USA - Vegas Tenaya | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Urology - Cathedral Rock | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Urology - Smoke Ranch | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact research@smcrf.org | |
Principal Investigator: John A. Ellerton | |
OptumCare Cancer Care at MountainView | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Urology Specialists of Nevada - Northwest | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Alliance for Childhood Diseases/Cure 4 the Kids Foundation | Recruiting |
Las Vegas, Nevada, United States, 89135 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada - Town Center | Recruiting |
Las Vegas, Nevada, United States, 89144 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada-Summerlin | Recruiting |
Las Vegas, Nevada, United States, 89144 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Summerlin Hospital Medical Center | Recruiting |
Las Vegas, Nevada, United States, 89144 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Cancer Center-Medical Center | Suspended |
Las Vegas, Nevada, United States, 89148-2405 | |
Comprehensive Cancer Centers of Nevada | Recruiting |
Las Vegas, Nevada, United States, 89148 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
GenesisCare USA - Fort Apache | Recruiting |
Las Vegas, Nevada, United States, 89148 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
OptumCare Cancer Care at Fort Apache | Recruiting |
Las Vegas, Nevada, United States, 89148 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada - Central Valley | Recruiting |
Las Vegas, Nevada, United States, 89169 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
University Cancer Center | Recruiting |
Las Vegas, Nevada, United States, 89169 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Hope Cancer Care of Nevada-Pahrump | Recruiting |
Pahrump, Nevada, United States, 89048 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Renown Regional Medical Center | Recruiting |
Reno, Nevada, United States, 89502 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Saint Mary's Regional Medical Center | Recruiting |
Reno, Nevada, United States, 89503 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Radiation Oncology Associates | Recruiting |
Reno, Nevada, United States, 89509 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
United States, New Hampshire | |
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center | Recruiting |
Lebanon, New Hampshire, United States, 03756 | |
Contact: Site Public Contact 800-639-6918 cancer.research.nurse@dartmouth.edu | |
Principal Investigator: John D. Seigne | |
United States, New Jersey | |
Hackensack University Medical Center | Recruiting |
Hackensack, New Jersey, United States, 07601 | |
Contact: Site Public Contact 201-996-2879 | |
Principal Investigator: Robert S. Alter | |
United States, New Mexico | |
University of New Mexico Cancer Center | Recruiting |
Albuquerque, New Mexico, United States, 87102 | |
Contact: Site Public Contact 505-925-0348 HSC-ClinicalTrialInfo@salud.unm.edu | |
Principal Investigator: Neda Hashemi Sadraei | |
United States, New York | |
Roswell Park Cancer Institute | Recruiting |
Buffalo, New York, United States, 14263 | |
Contact: Site Public Contact 800-767-9355 askroswell@roswellpark.org | |
Principal Investigator: Saby George | |
Northwell Health/Center for Advanced Medicine | Recruiting |
Lake Success, New York, United States, 11042 | |
Contact: Site Public Contact 516-734-8896 | |
Principal Investigator: Thomas P. Bradley | |
University of Rochester | Recruiting |
Rochester, New York, United States, 14642 | |
Contact: Site Public Contact 585-275-5830 | |
Principal Investigator: Paul M. Barr | |
Phelps Memorial Hospital Center | Recruiting |
Sleepy Hollow, New York, United States, 10591 | |
Contact: Site Public Contact 914-366-1600 | |
Principal Investigator: Thomas P. Bradley | |
United States, North Carolina | |
Southeastern Medical Oncology Center-Clinton | Active, not recruiting |
Clinton, North Carolina, United States, 28328 | |
Southeastern Medical Oncology Center-Goldsboro | Active, not recruiting |
Goldsboro, North Carolina, United States, 27534 | |
Southeastern Medical Oncology Center-Jacksonville | Active, not recruiting |
Jacksonville, North Carolina, United States, 28546 | |
United States, Ohio | |
UH Seidman Cancer Center at UH Avon Health Center | Recruiting |
Avon, Ohio, United States, 44011 | |
Contact: Site Public Contact 800-641-2422 | |
Principal Investigator: Pedro Barata | |
UHHS-Chagrin Highlands Medical Center | Recruiting |
Beachwood, Ohio, United States, 44122 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Pedro Barata | |
Indu and Raj Soin Medical Center | Recruiting |
Beavercreek, Ohio, United States, 45431 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Saint Elizabeth Boardman Hospital | Recruiting |
Boardman, Ohio, United States, 44512 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Dayton Physicians LLC-Miami Valley South | Recruiting |
Centerville, Ohio, United States, 45459 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Miami Valley Hospital South | Suspended |
Centerville, Ohio, United States, 45459 | |
University of Cincinnati Cancer Center-UC Medical Center | Recruiting |
Cincinnati, Ohio, United States, 45219 | |
Contact: Site Public Contact 513-584-7698 cancer@uchealth.com | |
Principal Investigator: Robert A. Franklin | |
Oncology Hematology Care Inc-Kenwood | Recruiting |
Cincinnati, Ohio, United States, 45236 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Case Western Reserve University | Recruiting |
Cleveland, Ohio, United States, 44106 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Pedro Barata | |
Ohio State University Comprehensive Cancer Center | Recruiting |
Columbus, Ohio, United States, 43210 | |
Contact: Site Public Contact 800-293-5066 Jamesline@osumc.edu | |
Principal Investigator: Shawn Dason | |
Miami Valley Hospital | Suspended |
Dayton, Ohio, United States, 45409 | |
Dayton Physician LLC-Miami Valley Hospital North | Recruiting |
Dayton, Ohio, United States, 45415 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Miami Valley Hospital North | Suspended |
Dayton, Ohio, United States, 45415 | |
Armes Family Cancer Center | Recruiting |
Findlay, Ohio, United States, 45840 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Blanchard Valley Hospital | Recruiting |
Findlay, Ohio, United States, 45840 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Orion Cancer Care | Recruiting |
Findlay, Ohio, United States, 45840 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Atrium Medical Center-Middletown Regional Hospital | Suspended |
Franklin, Ohio, United States, 45005-1066 | |
Dayton Physicians LLC-Atrium | Recruiting |
Franklin, Ohio, United States, 45005 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Dayton Physicians LLC-Wayne | Recruiting |
Greenville, Ohio, United States, 45331 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Wayne Hospital | Recruiting |
Greenville, Ohio, United States, 45331 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Greater Dayton Cancer Center | Recruiting |
Kettering, Ohio, United States, 45409 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Kettering Medical Center | Recruiting |
Kettering, Ohio, United States, 45429 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
UH Seidman Cancer Center at Lake Health Mentor Campus | Recruiting |
Mentor, Ohio, United States, 44060 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Pedro Barata | |
Springfield Regional Cancer Center | Suspended |
Springfield, Ohio, United States, 45504 | |
Springfield Regional Medical Center | Suspended |
Springfield, Ohio, United States, 45505 | |
University of Toledo | Suspended |
Toledo, Ohio, United States, 43614 | |
Dayton Physicians LLC - Troy | Recruiting |
Troy, Ohio, United States, 45373 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Upper Valley Medical Center | Suspended |
Troy, Ohio, United States, 45373 | |
Saint Joseph Warren Hospital | Recruiting |
Warren, Ohio, United States, 44484 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
University of Cincinnati Cancer Center-West Chester | Recruiting |
West Chester, Ohio, United States, 45069 | |
Contact: Site Public Contact 513-584-7698 cancer@uchealth.com | |
Principal Investigator: Robert A. Franklin | |
Saint Elizabeth Youngstown Hospital | Recruiting |
Youngstown, Ohio, United States, 44501 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
United States, Oklahoma | |
University of Oklahoma Health Sciences Center | Suspended |
Oklahoma City, Oklahoma, United States, 73104 | |
Mercy Hospital Oklahoma City | Recruiting |
Oklahoma City, Oklahoma, United States, 73120 | |
Contact: Site Public Contact 405-752-3402 | |
Principal Investigator: Jay W. Carlson | |
United States, Oregon | |
Kaiser Sunnyside Medical Center | Recruiting |
Clackamas, Oregon, United States, 97015 | |
Contact: Site Public Contact 503-335-2400 information@kpchr.org | |
Principal Investigator: Sandeep H. Mashru | |
Rogue Valley Medical Center | Active, not recruiting |
Medford, Oregon, United States, 97504 | |
Kaiser Permanente Northwest | Recruiting |
Portland, Oregon, United States, 97227 | |
Contact: Site Public Contact 503-335-2400 information@kpchr.org | |
Principal Investigator: Sandeep H. Mashru | |
Oregon Health and Science University | Recruiting |
Portland, Oregon, United States, 97239 | |
Contact: Site Public Contact 503-494-1080 trials@ohsu.edu | |
Principal Investigator: Christopher W. Ryan | |
United States, Pennsylvania | |
UPMC Altoona | Recruiting |
Altoona, Pennsylvania, United States, 16601 | |
Contact: Site Public Contact protocols@swog.org | |
Principal Investigator: Risa L. Wong | |
UPMC-Heritage Valley Health System Beaver | Recruiting |
Beaver, Pennsylvania, United States, 15009 | |
Contact: Site Public Contact 412-389-5208 haneydl@upmc.edu | |
Principal Investigator: Risa L. Wong | |
UPMC Hillman Cancer Center at Butler Health System | Recruiting |
Butler, Pennsylvania, United States, 16001 | |
Contact: Site Public Contact 412-389-5208 haneydl@upmc.edu | |
Principal Investigator: Risa L. Wong | |
UPMC Hillman Cancer Center Erie | Recruiting |
Erie, Pennsylvania, United States, 16505 | |
Contact: Site Public Contact 412-389-5208 haneydl@upmc.edu | |
Principal Investigator: Risa L. Wong | |
UPMC Cancer Center at UPMC Horizon | Recruiting |
Farrell, Pennsylvania, United States, 16121 | |
Contact: Site Public Contact protocols@swog.org | |
Principal Investigator: Risa L. Wong | |
UPMC Cancer Centers - Arnold Palmer Pavilion | Recruiting |
Greensburg, Pennsylvania, United States, 15601 | |
Contact: Site Public Contact 724-838-1900 | |
Principal Investigator: Risa L. Wong | |
IRMC Cancer Center | Recruiting |
Indiana, Pennsylvania, United States, 15701 | |
Contact: Site Public Contact 412-389-5208 haneydl@upmc.edu | |
Principal Investigator: Risa L. Wong | |
UPMC-Johnstown/John P. Murtha Regional Cancer Center | Recruiting |
Johnstown, Pennsylvania, United States, 15901 | |
Contact: Site Public Contact 814-534-4724 | |
Principal Investigator: Risa L. Wong | |
UPMC Cancer Center at UPMC McKeesport | Recruiting |
McKeesport, Pennsylvania, United States, 15132 | |
Contact: Site Public Contact 412-647-8073 | |
Principal Investigator: Risa L. Wong | |
UPMC Hillman Cancer Center - Monroeville | Recruiting |
Monroeville, Pennsylvania, United States, 15146 | |
Contact: Site Public Contact 412-389-5208 haneydl@upmc.edu | |
Principal Investigator: Risa L. Wong | |
UPMC Hillman Cancer Center - Part of Frick Hospital | Recruiting |
Mount Pleasant, Pennsylvania, United States, 15666 | |
Contact: Site Public Contact 412-389-5208 haneydl@upmc.edu | |
Principal Investigator: Risa L. Wong | |
Arnold Palmer Cancer Center Medical Oncology Norwin | Recruiting |
N. Huntingdon, Pennsylvania, United States, 15642 | |
Contact: Site Public Contact 412-389-5208 haneydl@upmc.edu | |
Principal Investigator: Risa L. Wong | |
UPMC Cancer Center-Natrona Heights | Recruiting |
Natrona Heights, Pennsylvania, United States, 15065 | |
Contact: Site Public Contact 724-230-3030 | |
Principal Investigator: Risa L. Wong | |
UPMC Hillman Cancer Center - New Castle | Recruiting |
New Castle, Pennsylvania, United States, 16105 | |
Contact: Site Public Contact 412-389-5208 haneydl@upmc.edu | |
Principal Investigator: Risa L. Wong | |
UPMC-Saint Margaret | Recruiting |
Pittsburgh, Pennsylvania, United States, 15215 | |
Contact: Site Public Contact 412-784-4900 | |
Principal Investigator: Risa L. Wong | |
University of Pittsburgh Cancer Institute (UPCI) | Recruiting |
Pittsburgh, Pennsylvania, United States, 15232 | |
Contact: Site Public Contact 412-647-8073 | |
Principal Investigator: Risa L. Wong | |
UPMC-Shadyside Hospital | Recruiting |
Pittsburgh, Pennsylvania, United States, 15232 | |
Contact: Site Public Contact 412-621-2334 | |
Principal Investigator: Risa L. Wong | |
UPMC-Passavant Hospital | Recruiting |
Pittsburgh, Pennsylvania, United States, 15237 | |
Contact: Site Public Contact 412-367-6454 | |
Principal Investigator: Risa L. Wong | |
UPMC-Saint Clair Hospital Cancer Center | Recruiting |
Pittsburgh, Pennsylvania, United States, 15243 | |
Contact: Site Public Contact 412-502-3920 | |
Principal Investigator: Risa L. Wong | |
UPMC Cancer Center at UPMC Northwest | Recruiting |
Seneca, Pennsylvania, United States, 16346 | |
Contact: Site Public Contact 814-676-7900 | |
Principal Investigator: Risa L. Wong | |
UPMC Cancer Center-Uniontown | Recruiting |
Uniontown, Pennsylvania, United States, 15401 | |
Contact: Site Public Contact protocols@swog.org | |
Principal Investigator: Risa L. Wong | |
UPMC Cancer Center-Washington | Recruiting |
Washington, Pennsylvania, United States, 15301 | |
Contact: Site Public Contact protocols@swog.org | |
Principal Investigator: Risa L. Wong | |
UPMC West Mifflin-Cancer Center Jefferson | Recruiting |
West Mifflin, Pennsylvania, United States, 15122 | |
Contact: Site Public Contact 412-653-8100 | |
Principal Investigator: Risa L. Wong | |
United States, South Carolina | |
Prisma Health Cancer Institute - Spartanburg | Active, not recruiting |
Boiling Springs, South Carolina, United States, 29316 | |
Medical University of South Carolina | Recruiting |
Charleston, South Carolina, United States, 29425 | |
Contact: Site Public Contact 843-792-9321 hcc-clinical-trials@musc.edu | |
Principal Investigator: Robert L. Grubb | |
Prisma Health Cancer Institute - Easley | Active, not recruiting |
Easley, South Carolina, United States, 29640 | |
Prisma Health Cancer Institute - Butternut | Active, not recruiting |
Greenville, South Carolina, United States, 29605 | |
Prisma Health Cancer Institute - Faris | Active, not recruiting |
Greenville, South Carolina, United States, 29605 | |
Prisma Health Greenville Memorial Hospital | Active, not recruiting |
Greenville, South Carolina, United States, 29605 | |
Prisma Health Cancer Institute - Eastside | Active, not recruiting |
Greenville, South Carolina, United States, 29615 | |
Prisma Health Cancer Institute - Greer | Active, not recruiting |
Greer, South Carolina, United States, 29650 | |
Prisma Health Cancer Institute - Seneca | Active, not recruiting |
Seneca, South Carolina, United States, 29672 | |
United States, Texas | |
UT Southwestern Simmons Cancer Center - RedBird | Recruiting |
Dallas, Texas, United States, 75237 | |
Contact: Site Public Contact 214-648-7097 canceranswerline@utsouthwestern.edu | |
Principal Investigator: Suzanne M. Cole | |
UT Southwestern/Simmons Cancer Center-Dallas | Recruiting |
Dallas, Texas, United States, 75390 | |
Contact: Site Public Contact 214-648-7097 canceranswerline@UTSouthwestern.edu | |
Principal Investigator: Suzanne M. Cole | |
UT Southwestern/Simmons Cancer Center-Fort Worth | Recruiting |
Fort Worth, Texas, United States, 76104 | |
Contact: Site Public Contact 214-648-7097 canceranswerline@UTSouthwestern.edu | |
Principal Investigator: Suzanne M. Cole | |
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center | Recruiting |
Houston, Texas, United States, 77030 | |
Contact: Site Public Contact 713-798-1354 burton@bcm.edu | |
Principal Investigator: Aihua E. Yen | |
Ben Taub General Hospital | Recruiting |
Houston, Texas, United States, 77030 | |
Contact: Site Public Contact 713-873-2000 | |
Principal Investigator: Aihua E. Yen | |
UT Southwestern Clinical Center at Richardson/Plano | Recruiting |
Richardson, Texas, United States, 75080 | |
Contact: Site Public Contact 972-669-7044 Suzanne.cole@utsouthwestern.edu | |
Principal Investigator: Suzanne M. Cole | |
University of Texas Health Science Center at San Antonio | Recruiting |
San Antonio, Texas, United States, 78229 | |
Contact: Site Public Contact 210-450-3800 phoresearchoffice@uthscsa.edu | |
Principal Investigator: Deepak K. Pruthi | |
United States, Utah | |
University of Utah Sugarhouse Health Center | Recruiting |
Salt Lake City, Utah, United States, 84106 | |
Contact: Site Public Contact 888-424-2100 cancerinfo@hci.utah.edu | |
Principal Investigator: Alejandro Sanchez | |
Huntsman Cancer Institute/University of Utah | Recruiting |
Salt Lake City, Utah, United States, 84112 | |
Contact: Site Public Contact 888-424-2100 cancerinfo@hci.utah.edu | |
Principal Investigator: Alejandro Sanchez | |
George E Wahlen Department of Veterans Affairs Medical Center | Recruiting |
Salt Lake City, Utah, United States, 84148 | |
Contact: Site Public Contact 801-582-1565 | |
Principal Investigator: Sumati V. Gupta | |
United States, Vermont | |
Norris Cotton Cancer Center-North | Recruiting |
Saint Johnsbury, Vermont, United States, 05819 | |
Contact: Site Public Contact 800-639-6918 cancer.research.nurse@hitchcock.org | |
Principal Investigator: John D. Seigne | |
United States, Washington | |
Overlake Medical Center | Suspended |
Bellevue, Washington, United States, 98004 | |
Valley Medical Center | Recruiting |
Renton, Washington, United States, 98055 | |
Contact: Site Public Contact 425-228-3440 research@valleymed.org | |
Principal Investigator: John A. Ellerton | |
North Star Lodge Cancer Center at Yakima Valley Memorial Hospital | Recruiting |
Yakima, Washington, United States, 98902 | |
Contact: Site Public Contact 509-574-3535 Memorial-ClinicalTrials@yvmh.org | |
Principal Investigator: John A. Ellerton | |
United States, Wisconsin | |
Aurora Cancer Care-Southern Lakes VLCC | Recruiting |
Burlington, Wisconsin, United States, 53105 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Adam P. Siegel | |
Marshfield Clinic-Chippewa Center | Recruiting |
Chippewa Falls, Wisconsin, United States, 54729 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Seth O. Fagbemi | |
Marshfield Medical Center-EC Cancer Center | Recruiting |
Eau Claire, Wisconsin, United States, 54701 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Seth O. Fagbemi | |
Aurora Health Care Germantown Health Center | Recruiting |
Germantown, Wisconsin, United States, 53022 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Adam P. Siegel | |
Aurora Cancer Care-Grafton | Recruiting |
Grafton, Wisconsin, United States, 53024 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Adam P. Siegel | |
Aurora BayCare Medical Center | Recruiting |
Green Bay, Wisconsin, United States, 54311 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Adam P. Siegel | |
Aurora Cancer Care-Kenosha South | Recruiting |
Kenosha, Wisconsin, United States, 53142 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Adam P. Siegel | |
Marshfield Clinic - Ladysmith Center | Recruiting |
Ladysmith, Wisconsin, United States, 54848 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Seth O. Fagbemi | |
Aurora Bay Area Medical Group-Marinette | Recruiting |
Marinette, Wisconsin, United States, 54143 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Adam P. Siegel | |
Marshfield Medical Center-Marshfield | Recruiting |
Marshfield, Wisconsin, United States, 54449 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Seth O. Fagbemi | |
Froedtert Menomonee Falls Hospital | Recruiting |
Menomonee Falls, Wisconsin, United States, 53051 | |
Contact: Site Public Contact 262-257-5100 | |
Principal Investigator: Kathryn A. Bylow | |
Aurora Cancer Care-Milwaukee | Recruiting |
Milwaukee, Wisconsin, United States, 53209 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Adam P. Siegel | |
Aurora Saint Luke's Medical Center | Recruiting |
Milwaukee, Wisconsin, United States, 53215 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Adam P. Siegel | |
Medical College of Wisconsin | Recruiting |
Milwaukee, Wisconsin, United States, 53226 | |
Contact: Site Public Contact 414-805-3666 | |
Principal Investigator: Kathryn A. Bylow | |
Aurora Sinai Medical Center | Recruiting |
Milwaukee, Wisconsin, United States, 53233 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Adam P. Siegel | |
Marshfield Clinic-Minocqua Center | Recruiting |
Minocqua, Wisconsin, United States, 54548 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Seth O. Fagbemi | |
Cancer Center of Western Wisconsin | Recruiting |
New Richmond, Wisconsin, United States, 54017 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Drexel Town Square Health Center | Recruiting |
Oak Creek, Wisconsin, United States, 53154 | |
Contact: Site Public Contact 414-805-0505 | |
Principal Investigator: Kathryn A. Bylow | |
Vince Lombardi Cancer Clinic - Oshkosh | Recruiting |
Oshkosh, Wisconsin, United States, 54904 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Adam P. Siegel | |
Aurora Cancer Care-Racine | Recruiting |
Racine, Wisconsin, United States, 53406 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Adam P. Siegel | |
Marshfield Medical Center-Rice Lake | Recruiting |
Rice Lake, Wisconsin, United States, 54868 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Seth O. Fagbemi | |
Vince Lombardi Cancer Clinic-Sheboygan | Recruiting |
Sheboygan, Wisconsin, United States, 53081 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Adam P. Siegel | |
Marshfield Medical Center-River Region at Stevens Point | Recruiting |
Stevens Point, Wisconsin, United States, 54482 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Seth O. Fagbemi | |
Aurora Medical Center in Summit | Recruiting |
Summit, Wisconsin, United States, 53066 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Adam P. Siegel | |
Vince Lombardi Cancer Clinic-Two Rivers | Recruiting |
Two Rivers, Wisconsin, United States, 54241 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Adam P. Siegel | |
Marshfield Clinic-Wausau Center | Recruiting |
Wausau, Wisconsin, United States, 54401 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Seth O. Fagbemi | |
Aurora Cancer Care-Milwaukee West | Recruiting |
Wauwatosa, Wisconsin, United States, 53226 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Adam P. Siegel | |
Aurora West Allis Medical Center | Recruiting |
West Allis, Wisconsin, United States, 53227 | |
Contact: Site Public Contact 414-302-2304 ncorp@aurora.org | |
Principal Investigator: Adam P. Siegel | |
Froedtert West Bend Hospital/Kraemer Cancer Center | Recruiting |
West Bend, Wisconsin, United States, 53095 | |
Contact: Site Public Contact 414-805-0505 | |
Principal Investigator: Kathryn A. Bylow | |
Marshfield Medical Center - Weston | Recruiting |
Weston, Wisconsin, United States, 54476 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Seth O. Fagbemi | |
Marshfield Clinic - Wisconsin Rapids Center | Recruiting |
Wisconsin Rapids, Wisconsin, United States, 54494 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Seth O. Fagbemi |
Responsible Party: | SWOG Cancer Research Network |
ClinicalTrials.gov Identifier: | NCT04510597 |
Other Study ID Numbers: |
S1931 NCI-2020-04442 ( Other Identifier: NCI ) |
First Posted: | August 12, 2020 Key Record Dates |
Last Update Posted: | August 14, 2023 |
Last Verified: | August 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | Yes |
Studies a U.S. FDA-regulated Device Product: | No |
Product Manufactured in and Exported from the U.S.: | No |
Carcinoma Carcinoma, Renal Cell Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Neoplasms Adenocarcinoma Kidney Neoplasms Urologic Neoplasms |
Urogenital Neoplasms Neoplasms by Site Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Urogenital Diseases Kidney Diseases Urologic Diseases Male Urogenital Diseases |